DePuy Synthes Receives 510(k) FDA Clearance for VELYS™ Robotic-Assisted Solution Designed for Use with the ATTUNE® Total Knee System

The VELYS™ Robotic-Assisted Solution is adaptable technology that helps simplify surgeons’ existing workflow, and is designed around how surgeons plan, execute and perform surgery for total knee replacement

The VELYS Robotic-Assisted Solution Becomes the Latest Addition to the company’s VELYS Digital Surgery Platform

PALM BEACH GARDENS, Fla.Jan. 19, 2021 /PRNewswire/ — Today, The Johnson & Johnson Medical Devices Companies* announced that DePuy Synthes** has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the VELYS™ Robotic-Assisted Solution designed for use with the ATTUNE® Total Knee System and its cleared indications for use. It will become part of the broader VELYS Digital Surgery Platform of connected technologies.